| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 701022 | Null | 0.0392716453377535 | 0.26192761 |
| NSC 701023 | Aceanthryleno[1,2-b]quinoxaline, 12-nitro- | 0.0392716453377535 | 0.04105075 |
| NSC 706992 | Null | 0.0392716453377535 | -0.019694819 |
| NSC 709974 | Null | 0.0392716453377535 | 0.42274122 |
| NSC 715481 | Null | 0.0392716453377535 | 0.031785533 |
| NSC 724783 | [1,5-dimethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetra cyclo[10.3.1.04,13.08,13]hexadec-9-en-9-yl]-N,N-bis{[1,5-dim ethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10 .3.1.04,13.08,13 | 0.0392716453377535 | 0.2007453 |
| NSC 726217 | Combretastatin A4-analogue | 0.0392716453377535 | 0.10813718 |
| NSC 726442 | 4,11-dihydroxy-3-{[4-(2-hydroxyethyl)-1-piperazinyl]methyl}- 1H-naphtho[2,3-f]indole-5,10-dione dihydrochloride | 0.0392716453377535 | 0.30222378 |
| NSC 727620 | 6-[3-(2-Aminoethylamino)]-bis{1-propyl)-5,6-dihydro-2,3-dime thoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquin oline} dihydrochloride | 0.0392716453377535 | 0.22943413 |
| NSC 732205 | Null | 0.0392716453377535 | 0.47888336 |